Mark James Litton insider trades

Open-market stock purchases and sales by Mark James Litton, PRESIDENT and CEO at LeonaBio, Inc, from SEC Form 4 filings since May 7, 2014.

Recent trades

DateStockTradeValue
Apr 9, 2026LONA LeonaBio, IncBought (not open market)—
Mar 4, 2026LONA LeonaBio, IncSold$27.7K
Mar 3, 2026LONA LeonaBio, IncBought (not open market)—
Jan 2, 2026ATHA Athira Pharma, IncSold$17.8K
Dec 31, 2025ATHA Athira Pharma, IncBought (not open market)—
Dec 24, 2025ATHA Athira Pharma, IncBought (not open market)—

Companies traded

  • LONA LeonaBio, Inc: 1 sale, last Apr 9, 2026
  • ATHA Athira Pharma, Inc: 7 sales, last Jan 2, 2026
  • ALPN Alpine Immune Sciences, Inc: other filings, last Feb 6, 2019
  • ALDR Alder Biopharmaceuticals Inc: 25 sales, last Jun 1, 2018

Get free alerts when Mark James Litton files a new trade →